20 (AIDX) Share-based Compensation (2025 - 2026)
20's (AIDX) quarterly Share-based Compensation came in at $100000.0 in Q1 2026, down 22.87% YoY from $129650.0 in Q1 2025, and down 85.81% on a QoQ basis from $704859.0 in Q4 2025.
20 (AIDX) Share-based Compensation (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Share-based Compensation data on file, last reported at $100000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 22.87% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Dec 2025 was $704859.0 (changed N/A YoY) and the FY2025 annual result came in at $704859.0, down 67.61% from the prior year.
- Share-based Compensation slipped to $100000.0 in Q1 2026, from $704859.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $704859.0 in Q4 2025 to a low of $100000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | 20 | 5.55 Mn | 1.00 Mn | 304,727.00 | 1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 704,859.00 |
| Dec 31, 2025 | 704,859.00 |
| Mar 31, 2025 | 129,650.00 |
| Mar 31, 2025 | 129,650.00 |